Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: ZIOPTAN® is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. US FDA label
Use: INDICATIONS AND USAGE TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. US FDA label
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Per ml ophthalmic solution: 15 mcg/5 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Tafluprost + Timolol as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
TapcomTafluprost + Timolol (As Maleate) | 15 mcg/ 5 mg per mL Ophthalmic Solution2.5 mL in 5 mL polypropylene container (Box of 1's) | Rx | Santen Pharmaceutical Co., Ltd. (Shiga Plant)Japan | Importer: Santen Philippines Inc. | DR-XY46011 | Sep 11, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .